Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease
about
Analysis of distribution of tumor- and preneoplasia-infiltrating lymphocytes using simultaneous Hoechst 33342 labeling and immunophenotyping.Lymphocytic infiltration and cytotoxicity under hypoxic conditions in the EMT6 mouse mammary tumor.In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic parameters.Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancerLacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasmsExpression of MHC products and leucocyte differentiation antigens in gynaecological neoplasms: an immunohistological analysis of the tumour cells and infiltrating leucocytesLymphocytopenia as an independent predictor of early recurrence in breast cancer.Expression of histocompatibility antigens and characterisation of mononuclear cell infiltrates in human renal cell carcinomasHLA-DR antigens on differentiating human mammary gland epithelium and breast tumours.Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.Macrophages in human breast disease: a quantitative immunohistochemical study.Reduction or loss of HLA-A,B,C antigens in colorectal carcinoma appears not to influence survival.Expression of class I and II major histocompatibility complex antigens in Wilms' tumour and normal developing human kidney.Inhibition of HLA class I antigen and mRNA expression induced by Rous sarcoma virus in transformed human fibroblasts.Applications of monoclonal antibodies to the in situ detection of human leucocytes.Activation of lymphocyte anti-tumour responses in man: effector heterogeneity and the search for immunomodulators.Autologous graft-versus-host disease.Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression.Natural killer-cell activity under conditions reflective of tumor micro-environment.Quantitative immunohistochemical analysis of mononuclear infiltrates in breast carcinomas--correlation with tumour differentiation.Expression of HLA-A, -B, -C, -DR, -DP, -DQ, and of HLA-D-associated invariant chain (Ii) in non-neoplastic mammary epithelium, fibroadenoma, adenoma, and carcinoma of the breast.Loss of polymorphic A and B locus HLA antigens in colon carcinoma.Study of the relationship between immunohistologically demonstrated lymphocytes infiltrating human breast carcinomas and patients' survival.Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast.The relationship between epithelial Ia expression and the inflammatory cell infiltrate during experimental oral carcinogenesis.Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy.HLA-D antigen expression and Langerhans' cell infiltrates in thyroid tumors
P2860
Q33207809-224802B2-34CA-44B4-B3B5-E0738B73AC20Q34449663-83E38632-CB83-4A48-809E-1EEEA1119196Q35856477-5CFD9C3A-E892-42EE-B3BE-5F57967153AEQ35982247-0E631543-0B4E-46C9-8303-A27C81BB2A66Q35983100-E92B6BC0-7968-48E6-B64C-C6A698A5787EQ35991977-5D186EC1-FCEC-4606-99B3-618AFB010A3AQ35992665-DAD3BF38-4452-4986-BA97-210A2859A492Q36027586-F4B993C7-99DA-44F0-865F-B42ED3BD273AQ36028316-05137461-E78E-4408-A027-831FD900A79CQ36029446-A84AC239-93F0-44AD-8D7D-64393AE76249Q36356745-88D8E14B-7D4F-4E00-A03A-54BDC64E57D0Q36465864-CCF5546A-5E23-4FBD-969B-7ADC1F562B9BQ36466197-3162B0E5-5826-4E23-86D0-5E84013A8643Q36466840-58BACD21-8660-4DB9-91F3-E00F65750844Q37480901-054C3B3B-4DCB-4412-A2D7-34A3DC36AB35Q39479827-C898EF85-BC03-48AD-A21B-91851D0D18B9Q39763930-748C75BC-4CA6-4BB9-87A7-633261E65877Q41148029-D2A07109-182D-4352-A0C4-F2AB3877A427Q41151353-3456529A-322E-4016-941E-FEB469515269Q41673787-B988D0B4-95EE-47B2-8B2E-612DEE838C97Q41884466-5D605699-2B9E-461C-B960-9CBB8D4C34B7Q42768744-7D3E87CE-2257-4129-ACD1-7928CD52BC4FQ43050288-8A91EF3D-AEE1-41E1-A922-7F2D3AC74865Q43495551-1C270B85-0EF2-47EA-A137-98C843B7674BQ43600961-150B46B7-C9C5-4A33-BB0D-9D14E96A956BQ43651719-E6A1030B-6334-42DC-B730-B88A7C69F676Q44061807-07B73BAF-CA50-4B93-B304-E902C2945ACCQ57795228-580C6E78-D8B5-447F-B09F-B327010DFC03
P2860
Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Expression of major histocompa ...... malignant human breast disease
@ast
Expression of major histocompa ...... malignant human breast disease
@en
type
label
Expression of major histocompa ...... malignant human breast disease
@ast
Expression of major histocompa ...... malignant human breast disease
@en
prefLabel
Expression of major histocompa ...... malignant human breast disease
@ast
Expression of major histocompa ...... malignant human breast disease
@en
P2093
P2860
P356
P1476
Expression of major histocompa ...... malignant human breast disease
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1984.28
P407
P577
1984-02-01T00:00:00Z
P5875
P6179
1021073452